Search Results 101-110 of 17047 for hypercoagulable

  1. The ENCIRCLE Trial - Mayo Clinic

    ... hypercoagulable states; Refusal of blood products. Female who is pregnant or lactating. Estimated life expectancy < 12 months due to non-cardiac conditions ...

  2. A Study to Evaluate the Pharmacokinetics of Low-Dose Bevacuzimab in Reducing Free Plasma VEGF-A in Hemodialysis Patients - Mayo Clinic

    Documented hypercoagulable state or history of 2 or more DVTs or other spontaneous intravascular thrombotic events; Bleeding diathesis; Anemia with a ...

  3. Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation - Mayo Clinic

    * History of a thromboembolic event, known hypercoagulable state, or condition requiring long term anticoagulation * Positive T- or B-cell crossmatch that ...

  4. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

    Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Bevacizumab blocks the ability of tumors to grow new blood vessels and ...

  5. https://www.mayoclinic.org/~/media/FD382661FD544C6CB4A38FC785855FAB

  6. A Study to Evaluate Gemcitabine and MK-3475 (Pembrolizumab) to Treat Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mayo Clinic

    The purpose of this study is to assess the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose ...

  7. The ICE WATCHMAN Trial - Mayo Clinic

    Patient has contraindication for short term anticoagulation. The patient has history of a hypercoagulable state per medical record documentation. Pregnancy or ...

  8. High blood protein When to see a doctor - Mayo Clinic

    A total protein test may be done. Other, more-specific tests, including serum protein electrophoresis (SPEP), can help find the exact source, such as the liver ...

  9. ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve - Mayo Clinic

    Hypercoagulable state or other condition that increases risk of thrombosis 24. Absolute contraindications or allergy to iodinated contrast that cannot be ...

  10. Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer - Mayo Clinic

    ... hypercoagulability syndromes (patients with a history of pulmonary embolism or deep vein thrombosis (DVT) are allowed on study if they are also on ...